Filter
960
Text search:
poor
quality
medicines
Featured
Recommendations
113
New Publications
277
Language
Document type
No document type
538
Studies & Reports
166
Guidelines
122
Strategic & Response Plan
50
Manuals
43
Training Material
18
Situation Updates
9
Fact sheets
7
Resource Platforms
4
Infographics
2
Brochures
1
Countries / Regions
India
57
Kenya
43
Global
42
Ethiopia
30
South Africa
28
Uganda
26
Malawi
25
Ghana
22
Tanzania
19
Nepal
18
Sierra Leone
17
Nigeria
16
Africa
16
Western and Central Europe
15
Myanmar / Burma
14
Zambia
13
Rwanda
13
Bangladesh
12
Liberia
11
Namibia
11
Eastern Europe
10
Philippines
9
South–East Asia Region
9
Syria
8
Asia
8
Senegal
7
Zimbabwe
7
Mozambique
7
Ukraine
7
Congo, Democratic Republic of
6
Cambodia
6
Lesotho
6
Haiti
5
Sudan
5
Brazil
5
Middle East and North Africa
5
Latin America and the Carribbean
5
South Sudan
4
Botswana
4
Venezuela
4
Somalia
3
Afghanistan
3
Lebanon
3
Indonesia
3
North Macedonia
3
Bhutan
3
Tajikistan
3
Guinea
2
Cameroon
2
Pakistan
2
Eswatini/ Swaziland
2
Hungary
2
Sri Lanka
2
Yemen
2
Eastern Europe and Central Asia
2
Southern Africa
2
Russia
2
Kyrgyzstan
2
Georgia
2
United Kingdom
2
Morocco
1
Iraq
1
Jordan
1
Chad
1
Thailand
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Argentina
1
Burundi
1
Colombia
1
Mexico
1
East and Southern Africa
1
West and Central Africa
1
Western Pacific Region
1
Other region
1
Poland
1
Albania
1
Laos
1
Canada
1
Timor Leste/ East Timor
1
Lithuania
1
Moldova
1
Iran
1
Kazakhstan
1
Vietnam
1
Jamaica
1
Denmark
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
404
Clinical Guidelines
95
Public Health
61
Women & Child Health
52
Key Resources
36
Capacity Building
17
Pharmacy & Technologies
11
Annual Report MEDBOX
1
Toolboxes
HIV
80
TB
78
Mental Health
51
COVID-19
50
AMR
47
Pharmacy
44
Disability
35
Caregiver
30
NCDs
30
NTDs
24
Planetary Health
22
Conflict
18
Refugee
14
Ebola & Marburg
11
Natural Hazards
11
Global Health Education
9
Rapid Response
8
Health Financing Toolbox
7
Polio
4
Cholera
3
Zika
3
Malaria
3
2.0 Rapid Response
3
Specific Hazards
2
Social Ethics
2
Typhoon
1
J Pharm Pharm Sci (www.cspsCanada.org) 16(3) 441 - 455, 2013
This document outlines PAHO’s regional priorities for the year 2023 to sustain and scale up health emergency and humanitarian assistance in the Americas, with a focus on five priority countries currently facing a prolonged humanitarian crisis and recovering from recent acute emergencies: Colombia,
...
Research Paper, Accessed April 10,2019
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp
...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202
...
18 March 2020
WHO and public health authorities around the world are acting to contain the COVID-19 outbreak. However, this time of crisis is generating stress throughout the population. The considerations presented in this document have been developed by the WHO Department of Mental Health and S
...
Frequently asked questions on Antimicrobial resistance.
Background paper 11
The Independent Panel for Pandemic Preparedness and Response
May 2021
This article looks at the Baseline Standards developed by the International Society for Paediatric
Oncology (SIOP) for paediatric oncology nursing care in low- and middle-income countries. The
Baseline Standards lay the foundation for effective care and address barriers such as inadequate
staffin
...
Practical considerations
It provides more detailed and practical guidance for continuing services for each life stage across the life-course continuum. As such, both documents should be read and used together. The countries in South-East Asia and the Pacific regions would like to adapt the guidance
...
The results of the SHINE trial have been published in the NEJM today. SHINE looked at whether treatment for children with minimal TB could be reduced from 6 months to 4 months. It found that the four month treatment was as good as the standard six months treatment for children with minimal TB